NEI Research News

Herpes stromal keratitis is a debilitating vision condition that occurs in response to a herpes infection in the eye.

According to a National Institutes of Health (NIH)-funded clinical study, children with a type of autoimmune arthritis and associated eye inflammation are likely to experience disease recurrence when discontinuing a biologic therapy called adalimumab.

New research suggests long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of shingles-related eye inflammation, infection, and pain.

A new study reveals how the eye resolves inflammation in the eye disease autoimmune uveitis.

Researchers are searching for a new treatment target for a common complication of diabetes that can cause retinal blood vessels to break down, leak or become blocked.

According to a new study from the National Eye Institute (NEI), the configuration of DNA loops in developing immune cells dictates how effectively the cells fight infection.

A five-year grant will fund research investigating biological processes that contribute to defects in immune response in the eyes of those with diabetes and identify methods to reverse them.

The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study.

The September 14 workshop brought together multidisciplinary experts in extracellular vesicles – cell-secreted nanoparticles that mediate cell-cell communication.

Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research.